ArticleInfectious agents and cancer2018

Tenofovir disoproxil fumarate reduce incidence of HCC development in CHB-patients with compensated cirrhosis.

Ping Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.